Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1709-1715
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1709
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1709
Table 1 Clinical features and therapeutic status of two patients with chronic inflammatory demyelinating polyradiculoneuropathy
| Case | Sex/age | Disease Course (mo) | Number of recurrences | Pretreatment medication | Prednisone usage and dosage before tacrolimus | Tacrolimus | Therapeutic effect (ONLS score) | ||
| Dosage (mg/d) | Length of treatment (mo) | Before Tacrolimus | After 6 mo treatment | ||||||
| 1 | F/17 | 11 | 4 | IVIg; steroids | 40 mg 4 wk, 35 mg 4 wk, 30 mg was associated with onset of symptoms | 2 | 12 | 1 | 0 |
| 2 | M/27 | 60 | 4 | IVIg; steroids | - | 3 | 6 | 2 | 0 |
- Citation: Zhu WJ, Da YW, Chen H, Xu M, Lu Y, Di L, Duo JY. Tacrolimus treatment for relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy: Two case reports . World J Clin Cases 2022; 10(5): 1709-1715
- URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1709.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1709